register  quick_nav_bullet contact us  quick_nav_bullet about CBI  quick_nav_bullet 1.800.817.8601  quick_nav_bullet
CBI Logo  
Conferences Webinars Sponsorship Marketing Opportunities Other Services Purchase CD-ROM About CBI
  About CBI
  Company Profile
  News & Press Releases
  Registration FAQs
  Press Pass FAQs
  Accreditation
  Careers
  Speaking Opportunities
  Elite Speaker Faculty
  Directions
  Contact Us

In the News

The Center for Business Intelligence announces The 2nd Annual Forum on Pharmaceutical Risk Management

Woburn, MA – The Center for Business Intelligence (CBI), in Association with REGISTRAT, will hold The 2nd Annual Forum on Pharmaceutical Risk Management on March 16-17, 2006 at the Crowne Plaza Philadelphia, Philadelphia, PA.

The biggest fear in the industry right now is product liability lawsuits. Due to the highly publicized events regarding drug withdrawals, companies need to implement risk management programs that allow better detection and adverse event reporting in the clinical and post-marketing stages. This need is augmented by the FDA’s new draft guidance, which requires drug companies to conduct additional post-marketing studies.

Industry leaders from Abbot Laboratories, AstraZeneca, Eli Lilly, Genzyme, GlasoSmithKline, Johnson & Johnson R&D, King Pharmaceuticals Inc., Pfizer, Wyeth Research and more, present industry perspectives and case studies regarding dynamics involved in risk management programs and how to successfully implement risk management during the product life cycle.

Topics of presentation include:

  • Registry use for safety surveillance, risk management and product support
  • Risk assessment from pre-clinical to clinical
  • An Update on the FDA’s drug safety oversight board
  • Risk assessment leverage and management in drug development
  • The role of large, streamlined trials and registries in risk management
  • Overcoming the special challenges of implementing safety surveillance studies
  • Reintroducing Lotronex—an exercise in behavior modification
  • Benefit Assesment and Benefit/Risk Balance
Exclusive Co-Sponsorship: REGISTRAT
Additional Sponsorship: i3Drug Safety, United Biosource Corporation, RTI Health Solutions, Covance, Outcome
Outstanding Support: Expert Opinion, PharmaVOICE, PharmCast, Drug Safety and Clinical Drug Investigation

CBI events provide real life case examples given by leading experts and are an excellent environment for networking.

For more information on this event or to register, contact CBI Registration at 800-817-8601, Fax 781-939-2490, visit http://www.cbinet.com/show_conference.cfm?confcode=HB629 or e-mail cbireg@cbinet.com.

 
Testimonials
“This conference was informative and encouraging, affording the opportunity to learn and collaborate across companies. We are all truthfully in this together!”
– Heather Resence, Supervisor Product Quality, Wyeth

“Excellent; Actionable nuggets to take back and implement”
– Kay Rayner Curling, Director, Work Life Solutions, SRA International

 
 
 
 
 
home | contact us | about CBI | privacy policy
© 2008 The Center for Business Intelligence